The global Point-of-care Molecular Diagnostic Solution market size is predicted to grow from US$ 5285 million in 2025 to US$ 9395 million in 2031; it is expected to grow at a CAGR of 10.1% from 2025 to 2031.
Molecular diagnostics involves the analysis of genetic material (DNA or RNA) to detect specific pathogens, mutations, or genetic markers associated with diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The “Point-of-care Molecular Diagnostic Solution Industry Forecast” looks at past sales and reviews total world Point-of-care Molecular Diagnostic Solution sales in 2024, providing a comprehensive analysis by region and market sector of projected Point-of-care Molecular Diagnostic Solution sales for 2025 through 2031. With Point-of-care Molecular Diagnostic Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point-of-care Molecular Diagnostic Solution industry.
This Insight Report provides a comprehensive analysis of the global Point-of-care Molecular Diagnostic Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Point-of-care Molecular Diagnostic Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Point-of-care Molecular Diagnostic Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point-of-care Molecular Diagnostic Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point-of-care Molecular Diagnostic Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of Point-of-care Molecular Diagnostic Solution market by product type, application, key players and key regions and countries.
Segmentation by Type:
Assays & kits
Instruments & Analyzers
Software & Services
Segmentation by Application:
Physicians’ Offices
Hospitals & ICUs
Research Institutes
Other End Users
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
F. Hoffmann-La Roche AG
Becton, Dickinson and Company
BioMerieux
Bio-Rad Laboratories, Inc.
Cepheid, Inc.
Danaher Corporation
Johnson and Johnson
Bayer Healthcare
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Point-of-care Molecular Diagnostic Solution Market Size (2020-2031)
2.1.2 Point-of-care Molecular Diagnostic Solution Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Point-of-care Molecular Diagnostic Solution by Country/Region (2020, 2024 & 2031)
2.2 Point-of-care Molecular Diagnostic Solution Segment by Type
2.2.1 Assays & kits
2.2.2 Instruments & Analyzers
2.2.3 Software & Services
2.3 Point-of-care Molecular Diagnostic Solution Market Size by Type
2.3.1 Point-of-care Molecular Diagnostic Solution Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Point-of-care Molecular Diagnostic Solution Market Size Market Share by Type (2020-2025)
2.4 Point-of-care Molecular Diagnostic Solution Segment by Application
2.4.1 Physicians’ Offices
2.4.2 Hospitals & ICUs
2.4.3 Research Institutes
2.4.4 Other End Users
2.5 Point-of-care Molecular Diagnostic Solution Market Size by Application
2.5.1 Point-of-care Molecular Diagnostic Solution Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Point-of-care Molecular Diagnostic Solution Market Size Market Share by Application (2020-2025)
3 Point-of-care Molecular Diagnostic Solution Market Size by Player
3.1 Point-of-care Molecular Diagnostic Solution Market Size Market Share by Player
3.1.1 Global Point-of-care Molecular Diagnostic Solution Revenue by Player (2020-2025)
3.1.2 Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Player (2020-2025)
3.2 Global Point-of-care Molecular Diagnostic Solution Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Point-of-care Molecular Diagnostic Solution by Region
4.1 Point-of-care Molecular Diagnostic Solution Market Size by Region (2020-2025)
4.2 Global Point-of-care Molecular Diagnostic Solution Annual Revenue by Country/Region (2020-2025)
4.3 Americas Point-of-care Molecular Diagnostic Solution Market Size Growth (2020-2025)
4.4 APAC Point-of-care Molecular Diagnostic Solution Market Size Growth (2020-2025)
4.5 Europe Point-of-care Molecular Diagnostic Solution Market Size Growth (2020-2025)
4.6 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size Growth (2020-2025)
5 Americas
5.1 Americas Point-of-care Molecular Diagnostic Solution Market Size by Country (2020-2025)
5.2 Americas Point-of-care Molecular Diagnostic Solution Market Size by Type (2020-2025)
5.3 Americas Point-of-care Molecular Diagnostic Solution Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Point-of-care Molecular Diagnostic Solution Market Size by Region (2020-2025)
6.2 APAC Point-of-care Molecular Diagnostic Solution Market Size by Type (2020-2025)
6.3 APAC Point-of-care Molecular Diagnostic Solution Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Point-of-care Molecular Diagnostic Solution Market Size by Country (2020-2025)
7.2 Europe Point-of-care Molecular Diagnostic Solution Market Size by Type (2020-2025)
7.3 Europe Point-of-care Molecular Diagnostic Solution Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Point-of-care Molecular Diagnostic Solution by Region (2020-2025)
8.2 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Type (2020-2025)
8.3 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Point-of-care Molecular Diagnostic Solution Market Forecast
10.1 Global Point-of-care Molecular Diagnostic Solution Forecast by Region (2026-2031)
10.1.1 Global Point-of-care Molecular Diagnostic Solution Forecast by Region (2026-2031)
10.1.2 Americas Point-of-care Molecular Diagnostic Solution Forecast
10.1.3 APAC Point-of-care Molecular Diagnostic Solution Forecast
10.1.4 Europe Point-of-care Molecular Diagnostic Solution Forecast
10.1.5 Middle East & Africa Point-of-care Molecular Diagnostic Solution Forecast
10.2 Americas Point-of-care Molecular Diagnostic Solution Forecast by Country (2026-2031)
10.2.1 United States Market Point-of-care Molecular Diagnostic Solution Forecast
10.2.2 Canada Market Point-of-care Molecular Diagnostic Solution Forecast
10.2.3 Mexico Market Point-of-care Molecular Diagnostic Solution Forecast
10.2.4 Brazil Market Point-of-care Molecular Diagnostic Solution Forecast
10.3 APAC Point-of-care Molecular Diagnostic Solution Forecast by Region (2026-2031)
10.3.1 China Point-of-care Molecular Diagnostic Solution Market Forecast
10.3.2 Japan Market Point-of-care Molecular Diagnostic Solution Forecast
10.3.3 Korea Market Point-of-care Molecular Diagnostic Solution Forecast
10.3.4 Southeast Asia Market Point-of-care Molecular Diagnostic Solution Forecast
10.3.5 India Market Point-of-care Molecular Diagnostic Solution Forecast
10.3.6 Australia Market Point-of-care Molecular Diagnostic Solution Forecast
10.4 Europe Point-of-care Molecular Diagnostic Solution Forecast by Country (2026-2031)
10.4.1 Germany Market Point-of-care Molecular Diagnostic Solution Forecast
10.4.2 France Market Point-of-care Molecular Diagnostic Solution Forecast
10.4.3 UK Market Point-of-care Molecular Diagnostic Solution Forecast
10.4.4 Italy Market Point-of-care Molecular Diagnostic Solution Forecast
10.4.5 Russia Market Point-of-care Molecular Diagnostic Solution Forecast
10.5 Middle East & Africa Point-of-care Molecular Diagnostic Solution Forecast by Region (2026-2031)
10.5.1 Egypt Market Point-of-care Molecular Diagnostic Solution Forecast
10.5.2 South Africa Market Point-of-care Molecular Diagnostic Solution Forecast
10.5.3 Israel Market Point-of-care Molecular Diagnostic Solution Forecast
10.5.4 Turkey Market Point-of-care Molecular Diagnostic Solution Forecast
10.6 Global Point-of-care Molecular Diagnostic Solution Forecast by Type (2026-2031)
10.7 Global Point-of-care Molecular Diagnostic Solution Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Point-of-care Molecular Diagnostic Solution Forecast
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Point-of-care Molecular Diagnostic Solution Product Offered
11.1.3 Abbott Laboratories Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 F. Hoffmann-La Roche AG
11.2.1 F. Hoffmann-La Roche AG Company Information
11.2.2 F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Product Offered
11.2.3 F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 F. Hoffmann-La Roche AG Main Business Overview
11.2.5 F. Hoffmann-La Roche AG Latest Developments
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Information
11.3.2 Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Product Offered
11.3.3 Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Becton, Dickinson and Company Main Business Overview
11.3.5 Becton, Dickinson and Company Latest Developments
11.4 BioMerieux
11.4.1 BioMerieux Company Information
11.4.2 BioMerieux Point-of-care Molecular Diagnostic Solution Product Offered
11.4.3 BioMerieux Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 BioMerieux Main Business Overview
11.4.5 BioMerieux Latest Developments
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Bio-Rad Laboratories, Inc. Company Information
11.5.2 Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Product Offered
11.5.3 Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bio-Rad Laboratories, Inc. Main Business Overview
11.5.5 Bio-Rad Laboratories, Inc. Latest Developments
11.6 Cepheid, Inc.
11.6.1 Cepheid, Inc. Company Information
11.6.2 Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Product Offered
11.6.3 Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Cepheid, Inc. Main Business Overview
11.6.5 Cepheid, Inc. Latest Developments
11.7 Danaher Corporation
11.7.1 Danaher Corporation Company Information
11.7.2 Danaher Corporation Point-of-care Molecular Diagnostic Solution Product Offered
11.7.3 Danaher Corporation Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Danaher Corporation Main Business Overview
11.7.5 Danaher Corporation Latest Developments
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Information
11.8.2 Johnson and Johnson Point-of-care Molecular Diagnostic Solution Product Offered
11.8.3 Johnson and Johnson Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Johnson and Johnson Main Business Overview
11.8.5 Johnson and Johnson Latest Developments
11.9 Bayer Healthcare
11.9.1 Bayer Healthcare Company Information
11.9.2 Bayer Healthcare Point-of-care Molecular Diagnostic Solution Product Offered
11.9.3 Bayer Healthcare Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Bayer Healthcare Main Business Overview
11.9.5 Bayer Healthcare Latest Developments
12 Research Findings and Conclusion
Ěý
Ěý
*If Applicable.
